MedPath

Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.

Conditions
Quality of Life
Covid19
Post Traumatic Stress Disorder
Registration Number
NCT04860687
Lead Sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
Brief Summary

Acute respiratory insufficiency is one of the principal causes of intensive care admission for COVID 19 positive patients. This may determine a variable mortality rate ranging from 25-30%.

In these patients, many days of non-invasive or invasive mechanical ventilation are needed to correct severe hypoxemia.

Mechanical ventilation is not a direct therapy but allows the clinicians to prolong the "time-to-recovery" interval necessary for COVID 19 respiratory insufficiency treatment.

Long intensive care stay, mechanical ventilation, the use of steroids and sedatives have an impact on the survivors.

Previous studies demonstrated that patients admitted to intensive care with non-COVID acute respiratory distress syndrome had a reduction in the quality of life even up to one year after discharge.

The aim of this study is to understand if COVID-19 related acute respiratory distress syndrome has a worse impact on the quality of life one year after discharge when compared with non-COVID-19 acute respiratory distress syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
309
Inclusion Criteria
  • patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency that requested non-invasive or invasive mechanical ventilation
Exclusion Criteria
  • history of dementia
  • history of behavior disorders
  • pre-existing tracheostomy
  • advanced oncologic disease
  • end-stage-organ disease (dialysis, or enlisted for organ transplantation)
  • no consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Short Form Health Survey 36One year after discharge

Evaluate the physical abilities of patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency. The scale ranges from 0 to 100, where 0 is the worse value and 100 is the best.

Secondary Outcome Measures
NameTimeMethod
Impact of Event Scale - Revised (IES-R)One year after discharge

Identify post traumatic stress disorder in patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency. The scale ranges from 0 to 88, where 0 is the best value and 88 the worst.

AgeOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the age of the patients

GenderOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the gender of the patients

ScholarshipOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the scholarship of the patients

Marital statusOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the marital status of the patients

SteroidsOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of steroids

Muscle relaxantsOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of muscle relaxants

Renal replacement therapyOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of renal replacement therapy

TracheostomyOne year after discharge

Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with tracheostomy

Trial Locations

Locations (8)

Anesthesia and Intensive Care, Academic Hospital of Catanzaro

๐Ÿ‡ฎ๐Ÿ‡น

Catanzaro, Calabria, Italy

Anesthesia and Intensive Care 2, Perugia Hospital

๐Ÿ‡ฎ๐Ÿ‡น

Perugia, Umbria, Italy

Anesthesia, Intensive Care and Pain Therapy, Academic Hospital "Federico II" of Naples

๐Ÿ‡ฎ๐Ÿ‡น

Naples, Campania, Italy

Anesthesia and Intensive Care 2, Academic Hospital of Parma

๐Ÿ‡ฎ๐Ÿ‡น

Parma, Emilia Romagna, Italy

Anesthesia and Intensive Care Department, Ravenna Hospital

๐Ÿ‡ฎ๐Ÿ‡น

Ravenna, Emilia Romagna, Italy

Department of Anesthesia and Intensive Care, Academic Hospital of Udine

๐Ÿ‡ฎ๐Ÿ‡น

Udine, Friuli Venezia Giulia, Italy

Anesthesia and Intensive Care 1, Hospital of Trento

๐Ÿ‡ฎ๐Ÿ‡น

Trento, Trentino Alto Adige, Italy

Anesthesia and Intensive Care, Academic Hospital of Ferrara

๐Ÿ‡ฎ๐Ÿ‡น

Ferrara, Emilia Romagna, Italy

ยฉ Copyright 2025. All Rights Reserved by MedPath